Test Price
2,800 AEDโ Home Collection Available
DNAJC6 Gene (PARK19) Juvenile-Onset Parkinson Disease Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Genetic Counselling by DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The DNAJC6 Gene (PARK19) Juvenile-Onset Parkinson Disease Genetic Test employs Next-Generation Sequencing to detect pathogenic variants in the PARK19 locus, confirming a hereditary form of parkinsonism that typically manifests before age 21. This test is critical for accurate diagnosis, family risk assessment, and guiding long-term neurological care.
| Feature | Our Test (DNAJC6 NGS) | Closest Alternative (Sanger / Panel) |
|---|---|---|
| Precision | >99.9% sensitivity, full gene coverage | Limited to known hotspots |
| Methodology | Next-Generation Sequencing (NGS) | Sanger sequencing / targeted panel |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| Sample Type | Blood, Extracted DNA, or FTA Card | Blood only |
Physician Insight & Safety Protocols
โAs a DHA-licensed Consultant Medical Geneticist, I emphasize that this genetic test confirms the molecular basis of juvenile-onset Parkinson disease but must always be correlated with clinical findings and a detailed three-generation pedigree. A positive result indicates a genetic predisposition, while a negative result does not exclude other genetic or idiopathic forms. Please discuss all results with your treating neurologist or genetic counsellor before making any clinical decisions.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
โ ๏ธ Medication Advisory & Exclusion Criteria
Do not discontinue prescribed medications without consulting your treating physician. The results of this test may influence medication decisions, but any changes must be supervised.
Exclusion Criteria: Inability to provide a blood or DNA sample after adequate attempts, lack of informed consent, or individuals under legal guardianship without proper authorization.
ER Red Flags: Acute psychiatric symptoms, rapid neurological deterioration, or any acute medical crisis โ seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the DNAJC6 gene test and who should consider it?
The DNAJC6 NGS test analyzes the entire PARK19 gene to detect variants causing juvenile-onset Parkinson disease. It is recommended for individuals with early-onset parkinsonian symptoms (before age 21), a positive family history, or unexplained movement disorders.
2. How is the test performed and how long do results take?
A simple blood draw, a drop of blood on an FTA card, or an extracted DNA sample is collected. Results are typically available within 3 to 4 weeks using high-throughput NGS technology.
3. What do the results mean for my health and my family?
A positive result confirms a genetic susceptibility to juvenile-onset Parkinson disease and enables early intervention and family screening. A negative result reduces but does not eliminate the possibility of another genetic or idiopathic form of parkinsonism.
UAE Regulatory & Data Privacy Adherence
Data Protection: All genetic data is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Lab Accreditation: ISO 9001:2015 certified (INT/EGQ/2509DA/3139). DNA Labs UAE is a DHA-licensed facility operating under License No. 1143.
Clinical & Logistical Metadata
| Test Name | DNAJC6 Gene (PARK19) Juvenile-Onset Parkinson Disease Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | G20 (Parkinson's disease) |
| LOINC Code | 21676-3 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians